These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 11458208

  • 21. Variability of genetic alterations in different sites of head and neck cancer.
    Rodrigo JP, Suárez C, González MV, Lazo PS, Ramos S, Coto E, Alvarez I, García LA, Martínez JA.
    Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
    [Abstract] [Full Text] [Related]

  • 22. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy.
    Nakamura K, Shioyama Y, Kawashima M, Saito Y, Nakamura N, Nakata K, Hareyama M, Takada T, Karasawa K, Watanabe T, Yorozu A, Tachibana H, Suzuki G, Hayabuchi N, Toba T, Yamada S.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1045-50. PubMed ID: 16682142
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation.
    Featherstone CJ, Clarke S, Jackson MA, Shannon KF, McNeil EB, Tin MM, Clifford A, O'Brien CJ.
    ANZ J Surg; 2004 Jul 15; 74(7):554-8. PubMed ID: 15230789
    [Abstract] [Full Text] [Related]

  • 27. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
    Lefebvre JL, Ang KK, Larynx Preservation Consensus Panel.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1293-303. PubMed ID: 19306746
    [Abstract] [Full Text] [Related]

  • 28. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
    Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I, Gabius HJ, Kiss R.
    Ann Surg Oncol; 2006 Jul 01; 13(7):999-1009. PubMed ID: 16788763
    [Abstract] [Full Text] [Related]

  • 29. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D, Dias FL, Ferreira CG, Araújo CM, Lima RA, Small IA, Kligerman J.
    ORL J Otorhinolaryngol Relat Spec; 2008 Jul 01; 70(6):381-8. PubMed ID: 18984974
    [Abstract] [Full Text] [Related]

  • 30. Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998.
    Barzan L, Talamini R, Franchin G, Vaccher E, Politi D, Minatel E, Gobitti C.
    Cancer; 2002 Aug 01; 95(3):540-52. PubMed ID: 12209746
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N, Cheewaruangroj W, Chintrakarn C, Pochanukul L.
    Arch Otolaryngol Head Neck Surg; 2008 Dec 01; 134(12):1305-11. PubMed ID: 19075127
    [Abstract] [Full Text] [Related]

  • 33. [Progression of larynx and hypopharynx cancer in the last ten years].
    Biszewska J, Rzewnicki I, Rózańska-Kudelska M, Wierzba U, Jackiewicz M.
    Pol Merkur Lekarski; 2005 Sep 01; 19(111):351-2. PubMed ID: 16358867
    [Abstract] [Full Text] [Related]

  • 34. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W, Wang L, Yao JC, Ajani JA, Wei D, Aldape KD, Xie K, Sawaya R, Huang S.
    Clin Cancer Res; 2005 Feb 15; 11(4):1386-93. PubMed ID: 15746037
    [Abstract] [Full Text] [Related]

  • 35. Nutritional status in head and neck cancer patients.
    Matthews TW, Lampe HB, Dragosz K.
    J Otolaryngol; 1995 Apr 15; 24(2):87-91. PubMed ID: 7602677
    [Abstract] [Full Text] [Related]

  • 36. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C.
    Laryngoscope; 2003 Jan 15; 113(1):167-72. PubMed ID: 12514403
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
    Liu M, Lawson G, Delos M, Jamart J, Chatelain B, Remacle M, Marbaix E.
    Eur Arch Otorhinolaryngol; 2003 Jan 15; 260(1):28-34. PubMed ID: 12520353
    [Abstract] [Full Text] [Related]

  • 38. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL.
    Bull Cancer; 2002 Apr 15; 89(4):411-7. PubMed ID: 12016041
    [Abstract] [Full Text] [Related]

  • 39. [Clinical analysis of posterior hypopharyngeal wall squamous cell carcinoma: a report of 36 cases].
    Wang JH, Qi YF, Tang PZ, Wen SX, Zhang ZM, Qin DX.
    Ai Zheng; 2005 Sep 15; 24(9):1106-10. PubMed ID: 16159434
    [Abstract] [Full Text] [Related]

  • 40. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
    Yamashita Y, Ishiguro Y, Sano D, Kimura M, Fujita K, Yoshida T, Horiuchi C, Taguchi T, Matsuda H, Mikami Y, Tsukuda M.
    Auris Nasus Larynx; 2007 Dec 15; 34(4):487-91. PubMed ID: 17337140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.